D-0883-2017 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0883-2017 was initiated by Dr. Reddy's Laboratories, Inc. on May 22, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification results observed for low dissolution. The recall status is terminated (terminated Nov 19, 2018). Affected quantity: 13,221 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 14, 2017
Initiation Date
May 22, 2017
Termination Date
Nov 19, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,221 cartons

Product description

Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-135-81

Reason for recall

Failed Dissolution Specifications: out of specification results observed for low dissolution.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: KB50471, Exp 06/17; KB50710, KB50710A, Exp 08/17; KB60198, Exp 02/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0883-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0883-2017. Report a data issue: hello@regdatalab.com.